Differential effects of arsenic on folate binding protein 2 (Folbp2) null and wild type fibroblasts

Toxicology Letters

Volumn 136, Issue 1, 2002, Pages 43-54

  Crandall, Lisa Zaddock ^a   Vorce, Roseann L ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

Arsenic; Cytotoxicity; Folate binding protein; Folic acid

Indexed keywords

ARSENIC; FOLATE BINDING PROTEIN; FOLATE BINDING PROTEIN 2; FOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; EMBRYO; FEMALE; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SUPPLEMENTATION;

ANIMALS; ARSENIC; CARRIER PROTEINS; CELL DIVISION; CELL MEMBRANE; CELLS, CULTURED; FEMALE; FIBROBLASTS; FOLIC ACID; FOLIC ACID DEFICIENCY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PREGNANCY; RECEPTORS, CELL SURFACE;

EID: 0037111431     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00286-2     Document Type: Article

References (38)

1. Armstrong C.W., Stroube R.B., Rubio T., Siudyla E.A., Miller G.B. Jr. Outbreak of fatal arsenic poisoning caused by contaminated drinking water. Arch. Environ. Health. 39:1984;276-279.
2. Aschengrau A., Zierler S., Cohen A. Quality of community drinking water and the occurrence of spontaneous abortion. Arch. Environ. Health. 44:1989;283-290.
3. Borzsonyi M., Bereczky A., Rudnai P., Csanady M., Horvath A. Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Arch. Toxicol. 66:1992;77-78.
4. Concha G., Vogler G., Lezcano D., Nermell B., Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci. 44:1998;185-190.
5. Das D., Chatterjee A., Samanta G., Mandal B., Chowdhury T.R., Chowdhury P.P., Chanda C., Basu G., Lodh D., et al. Arsenic contamination in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world. Analyst. 119:1994;168N-170N.
6. de Nonancourt-Didion M., Gueant J.L., Adjalla C., Chery C., Hatier R., Namour F. Overexpression of folate binding protein alpha is one of the mechanism explaining the adaptation of HT29 cells to high concentration of methotrexate. Cancer Lett. 171:2001;139-145.
7. DeSesso J.M. Teratogen update: inorganic arsenic. Teratology. 64:2001;170-173.
8. DeSesso J.M., Jacobson C.F., Scialli A.R., Farr C.H., Holson J.F. An assessment of the developmental toxicity of inorganic arsenic. Reprod. Toxicol. 12:1998;385-433.
9. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49:1999;5-14.
10. Gonsebatt M.E., Vega L., Montero R., Garcia-Vargas G., Del Razo L.M., Albores A., Cebrian M.E., Ostrosky-Wegman P. Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. Mutat. Res. 313:1994;293-299.
11. Hall A.H. Chronic arsenic poisoning. Toxicol. Lett. 128:2002;69-72.
12. Hamadeh H.K., Vargas M., Lee E., Menzel D.B. Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis. Biochem. Biophys. Res. Commun. 263:1999;446-449.
13. Healy S.M., Wildfang E., Zakharyan R.A., Aposhian H.V. Diversity of inorganic arsenite biotransformation. Biol. Trace Elem. Res. 68:1999;249-266.
14. Holson J.F., Stump D.G., Clevidence K.J., Knapp J.F., Farr C.H. Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats. Food Chem. Toxicol. 38:2000;459-466.
15. Hsueh Y.M., Cheng G.S., Wu M.M., Yu H.S., Kuo T.L., Chen C.J. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br. J. Cancer. 71:1995;109-114.
16. Jolliffe D.M. A history of the use of arsenicals in man. J. R. Soc. Med. 86:1993;287-289.
17. Lin S., Shi Q., Nix F.B., Styblo M., Beck M.A., Herbin-Davis K.M., Hall L.L., Simeonsson J.B., Thomas D.J. A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277:2002;10795-10803.
18. Marafante E., Vahter M. The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. Chem. Biol. Interact. 50:1984;49-57.
19. Mass M.J., Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386:1997;263-277.
20. Mazumder D.N., Das Gupta J., Santra A., Pal A., Ghose A., Sarkar S. Chronic arsenic toxicity in west Bengal - the worst calamity in the world. J. Indian Med. Assoc. 96:(4-7):1998;18.
21. Nemec M.D., Holson J.F., Farr C.H., Hood R.D. Developmental toxicity assessment of arsenic acid in mice and rabbits. Reprod. Toxicol. 12:1998;647-658.
22. Piedrahita J.A., Oetama B., Bennett G.D., van Waes J., Kamen B.A., Richardson J., Lacey S.W., Anderson R.G., Finnell R.H. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat. Genet. 23:1999;228-232.
23. Pollard J. Basic cell culture. Pollard J., Walker J., Basic Cell Culture Protocols. 1997;1-11 Humana Press, Totowa, NJ.
24. Rahman M.M., Chowdhury U.K., Mukherjee S.C., Mondal B.K., Paul K., Lodh D., Biswas B.K., Chanda C.R., Basu G.K., Saha K.C., Roy S., Das R., Palit S.K., Quamruzzaman Q., Chakraborti D. Chronic arsenic toxicity in Bangladesh and West Bengal, India - a review and commentary. J. Toxicol. Clin. Toxicol. 39:2001;683-700.
25. Ritter T.E., Fajardo O., Matsue H., Anderson R.G., Lacey S.W. Folate receptors targeted to clathrin-coated pits cannot regulate vitamin uptake. Proc. Natl. Acad. Sci. USA. 92:1995;3824-3828.
26. Ruan Y., Peterson M.H., Wauson E.M., Waes J.G., Finnell R.H., Vorce R.L. Folic acid protects SWV/Fnn embryo fibroblasts against arsenic toxicity. Toxicol. Lett. 117:2000;129-137.
27. Smith A.H., Goycolea M., Haque R., Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147:1998;660-669.
28. Solo-Gabriele H.M., Townsend T.G., Messick B., Calitu V. Characteristics of chromated copper arsenate-treated wood ash. J. Hazard Mater. 89:2002;213-232.
29. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299.
30. Trouba K.J., Wauson E.M., Vorce R.L. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicol. Appl. Pharmacol. 164:2000a;161-170.
31. Trouba K.J., Wauson E.M., Vorce R.L. Sodium arsenite inhibits terminal differentiation of murine C3H 10T1/2 preadipocytes. Toxicol. Appl. Pharmacol. 168:2000b;25-35.
32. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 112-113:2000;209-217.
33. Wang X., Jansen G., Fan J., Kohler W.J., Ross J.F., Schornagel J., Ratnam M. Variant GPI structure in relation to membrane-associated functions of a murine folate receptor. Biochemistry. 35:1996;16305-16312.
34. Wlodarczyk B., Spiegelstein O., Gelineau-van Waes J., Vorce R.L., Lu X., Le C.X., Finnell R.H. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. Toxicol. Appl. Pharmacol. 177:2001;238-246.
35. Wlodarczyk B.J., Bennett G.D., Calvin J.A., Finnell R.H. Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. Reprod. Toxicol. 10:1996;447-454.
36. Wlodraczyk B., Bennett G.D., Calvin J.A., Craig J.C., Finnell R.H. Arsenic-induced alterations in embryonic transcription factor gene expression: implications for abnormal neural development. Dev. Genet. 18:1996;306-315.
37. Yu R.C., Hsu K.H., Chen C.J., Froines J.R. Arsenic methylation capacity and skin cancer. Cancer Epidemiol. Biomarkers Prev. 9:2000;1259-1262.
38. Zierler S., Theodore M., Cohen A., Rothman K.J. Chemical quality of maternal drinking water and congenital heart disease. Int. J. Epidemiol. 17:1988;589-594.